That report is from a number of years ago. It was ordered by my predecessor. Although I've read the report a number of times, I don't remember the specific numbers and what it said.
I do know that when we looked at it, we found there were a number of people who were prescribed mefloquine when there were existing contraindications to doing that. We have done a quality-of-care review on those particular files. We've also put in place a training program that all prescribers need to take, which reminds people of these issues. We also have screening forms, and everybody who's prescribed any of the anti-malarial medications has to go through all the contraindications, and sign it. There are black boxes on each one of those forms to highlight the specific contraindications.
We believe we've put in place a robust system. There is no other health system that I'm aware of in Canada that has gone to those lengths.
I should point out too that when Health Canada did their safety review on mefloquine, they found similar issues in the civilian prescribing population as well. This isn't unique to the military. I think this is something that happens in medical practice from time to time, and I do believe we've responded appropriately to it.